spacerspacerspacer

14-3.

spacer

Reduce hepatitis B.

Target and baseline:

Objective

Reduction in Hepatitis B

1997
Baseline

2010
Target

 

Adults

Rate per 100,000 Population

14-3a.

19 to 24 years

24.0

2.4

14-3b.

25 to 39 years

20.2

5.1

14-3c.

40 years and older

15.0

3.8

 

High-risk groups

Number of Cases

14-3d.

Injection drug users

7,232

1,808

14-3e.

Heterosexually active persons

15,225

1,240

14-3f.

Men who have sex with men

7,232

1,808

14-3g.

Occupationally exposed workers

249

62

Target setting method: Better than the best for 14-3a, 14-3b, and 14-3c; 75 percent improvement for 14-3d, 14-3f, and 14-3g; 92 percent improvement for 14-3e.

Data sources: National Notifiable Disease Surveillance System (NNDSS), CDC, EPO; Sentinel Counties Study of Viral Hepatitis, CDC, NCID.

Select Age Groups, 1997

Hepatitis B Cases

14-3a.
Aged 19 to 24 Years

14-3b.
Aged 25 to 39 Years

14-3c.
Aged 40 Years and Older

Rate per 100,000

TOTAL

24.0

20.2

15.0

Race and ethnicity

American Indian or Alaska Native

16.0

20.1

10.9

Asian or Pacific Islander

42.2

30.4

33.2

Asian

DNC

DNC

DNC

Native Hawaiian and other Pacific Islander

DNC

DNC

DNC

Black or African American

48.3

32.5

27.6

White

10.4

10.2

7.4

 

Hispanic or Latino

16.9

16.0

18.1

Not Hispanic or Latino

25.2

20.7

14.8

Black or African American

50.6

34.1

28.4

White

10.3

10.2

7.1

Gender

Female

24.1

15.4

9.4

Male

22.5

24.1

20.8

Family income level

Poor

DNC

DNC

DNC

Near poor

DNC

DNC

DNC

Middle/high income

DNC

DNC

DNC

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.